TABLE OF CONTENTS
1 INTRODUCTION 41
1.1 OBJECTIVES OF THE STUDY 41
1.2 MARKET DEFINITION 41
1.3 OVERVIEW OF THE GLOBAL N95 MASK MARKET 41
1.4 LIMITATION 43
1.5 MARKETS COVERED 43
2 MARKET SEGMENTATION 47
2.1 MARKETS COVERED 47
2.2 GEOGRAPHICAL SCOPE 48
2.3 YEARS CONSIDERED FOR THE STUDY 49
2.4 CURRENCY AND PRICING 49
2.5 DBMR TRIPOD DATA VALIDATION MODEL 50
2.6 MULTIVARIATE MODELLING 53
2.7 PRODUCT SEGMENT LIFELINE CURVE 53
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 54
2.9 DBMR MARKET POSITION GRID 55
2.10 MARKET APPLICATION COVERAGE GRID 56
2.11 VENDOR SHARE ANALYSIS 57
2.12 SECONDARY SOURCES 58
2.13 ASSUMPTIONS 58
3 EXECUTIVE SUMMARY 59
3.1 PESTEL ANALYSIS 65
3.2 PORTER'S FIVE FORCES MODEL 66
4 INDUSTRY INSIGHTS 67
5 GLOBAL N95 MASK MARKET: REGULATORY FRAMEWORK 69
6 MARKET OVERVIEW 72
6.1 DRIVERS 74
6.1.1 INCREASE IN AIR POLLUTION LEVELS 74
6.1.2 RISING PREVALENCE OF RESPIRATORY DISEASES 75
6.1.3 MANDATORY OCCUPATIONAL SAFETY REGULATIONS FOR WORKERS IN VARIOUS INDUSTRY 75
6.1.4 INCREASED AWARENESS ABOUT THE SIGNIFICANT BENEFITS OF THE N95 MASK 77
6.2 RESTRAINTS 78
6.2.1 ENVIRONMENTAL CONCERNS ASSOCIATED WITH THE DISPOSAL OF N95 MASKS 78
6.2.2 INCREASED USE OF HOMEMADE MASK 79
6.3 OPPORTUNITIES 79
6.3.1 TECHNOLOGICAL ADVANCEMENT PROMOTING THE MANUFACTURING OF ECO-FRIENDLY N95 MASKS 79
6.3.2 RISING HEALTH AND SAFETY CONCERNS AGAINST INFECTIOUS DISEASES AMONG THE CONSUMERS 80
6.3.3 SIGNIFICANT RISE IN THE USE OF N95 MASKS IN THE HEALTHCARE INDUSTRY 81
6.4 CHALLENGES 82
6.4.1 LIMITED PRODUCTION CAPACITY AND MACHINERY FOR MEETING THE DESIRED QUALITY OF N95 MASKS 82
6.4.2 PHYSIOLOGICAL EFFECTS ASSOCIATED WITH THE PROLONGED USE OF N95 MASKS 83
7 GLOBAL N95 MASK MARKET, BY PRODUCT 84
7.1 OVERVIEW 85
7.2 STANDARD N95 MASKS 88
7.2.1 BY VALVES 89
7.2.1.1 WITHOUT VALVE 89
7.2.1.2 WITH VALVE 89
7.2.2 BY STYLE 89
7.2.2.1 MOLDED CUP 89
7.2.2.2 FLAT FOLD 89
7.3 SURGICAL N95 MASKS 90
7.3.1 BY VALVES 90
7.3.1.1 WITHOUT VALVE 91
7.3.1.2 WITH VALVE 91
7.3.2 BY STYLE 91
7.3.2.1 MOLDED CUP 91
7.3.2.2 FLAT FOLD 91
8 GLOBAL N95 MASK MARKET, BY APPLICATION 92
8.1 OVERVIEW 93
8.2 INFECTIOUS DISEASES 96
8.2.1 VIRUSES 97
8.2.2 BACTERIA 97
8.2.3 FUNGI 97
8.2.4 PARASITES 97
8.2.5 OTHERS 97
8.3 RESPIRATORY SAFETY 97
8.3.1 DUSTS 98
8.3.2 FUMES 98
8.3.3 MISTS 99
8.3.4 FOG 99
8.3.5 SPRAYS 99
8.3.6 SMOKES 99
8.3.7 GASES 99
8.3.8 VAPORS 99
8.3.9 OTHERS 99
8.4 ALLERGIES 99
8.4.1 POLLENS 100
8.4.2 DUST MITES 100
8.4.3 PARTICULATES 100
8.4.4 PET ALLERGENS 100
8.4.5 OTHERS 101
8.5 SURGERIES 101
9 GLOBAL N95 MASK MARKET, BY TYPE OF MATERIAL 102
9.1 OVERVIEW 103
9.2 POLYPROPYLENE (PP) 106
9.3 POLYURETHANE 106
9.4 POLYESTER 107
9.5 COTTON 108
10 GLOBAL N95 MASK MARKET, BY USABILITY 109
10.1 OVERVIEW 110
10.2 DISPOSABLE 113
10.3 REUSABLE 114
11 GLOBAL N95 MASK MARKET, BY SIZE 115
11.1 OVERVIEW 116
11.2 STANDARD SIZE 119
11.3 SMALL SIZE 119
11.4 OTHERS 120
12 GLOBAL N95 MASK MARKET, BY END USER 121
12.1 OVERVIEW 122
12.2 HOSPITALS 125
12.2.1 LONG-TERM CARE HOSPITALS 126
12.2.2 ACUTE CARE HOSPITALS 126
12.2.3 NURSING FACILITIES 126
12.2.4 REHABILITATION CENTERS 126
12.3 CLINICS 126
12.4 AMBULATORY SURGICAL CENTERS 127
12.5 DIAGNOSTIC LABORATORIES 127
12.6 PUBLIC SAFETY SERVICE ORGANIZATION 128
12.7 CONSTRUCTION COMPANIES 129
12.8 MANUFACTURING COMPANIES 130
12.9 OIL & GAS COMPANIES 131
12.10 INDIVIDUAL 131
12.11 OTHERS 132
13 GLOBAL N95 MASK MARKET, BY DISTRIBUTION CHANNEL 133
13.1 OVERVIEW 134
13.2 ONLINE SALES 137
13.2.1 ONLINE PHARMACIES 138
13.2.2 OTHERS 138
13.3 OFFLINE SALES 138
13.3.1 HOSPITAL PHARMACIES 139
13.3.2 SUPERMARKET/HYPERMARKET 139
13.3.3 DRUG STORE 139
13.3.4 RETAIL PHARMACIES 139
14 GLOBAL N95 MASK MARKET, BY REGION 140
14.1 OVERVIEW 141
14.2 NORTH AMERICA 147
14.2.1 U.S. 157
14.2.2 CANADA 162
14.2.3 MEXICO 167
14.3 EUROPE 172
14.3.1 GERMANY 183
14.3.2 U.K. 190
14.3.3 FRANCE 196
14.3.4 ITALY 203
14.3.5 SPAIN 209
14.3.6 BELGIUM 215
14.3.7 RUSSIA 222
14.3.8 NETHERLANDS 229
14.3.9 SWITZERLAND 236
14.3.10 TURKEY 242
14.3.11 REST OF EUROPE 249
14.4 ASIA-PACIFIC 250
14.4.1 CHINA 262
14.4.2 INDIA 268
14.4.3 JAPAN 274
14.4.4 SOUTH KOREA 280
14.4.5 SINGAPORE 287
14.4.6 AUSTRALIA 294
14.4.7 INDONESIA 300
14.4.8 THAILAND 307
14.4.9 MALAYSIA 314
14.4.10 PHILIPPINES 321
14.4.11 REST OF ASIA-PACIFIC 328
14.5 SOUTH AMERICA 329
14.5.1 BRAZIL 339
14.5.2 ARGENTINA 344
14.5.3 REST OF SOUTH AMERICA 349
14.6 MIDDLE EAST AND AFRICA 350
14.6.1 SAUDI ARABIA 360
14.6.2 SOUTH AFRICA 365
14.6.3 U.A.E. 370
14.6.4 ISRAEL 375
14.6.5 EGYPT 380
14.6.6 REST OF MIDDLE EAST AND AFRICA 385
15 GLOBAL N95 MASK MARKET, COMPANY LANDSCAPE 386
15.1 COMPANY SHARE ANALYSIS: GLOBAL 386
15.2 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 387
15.3 COMPANY SHARE ANALYSIS: NORTH AMERICA 388
15.4 COMPANY SHARE ANALYSIS: EUROPE 389
16 SWOT ANALYSIS 390
17 COMPANY PROFILE 391
17.1 3M 391
17.1.1 COMPANY SNAPSHOT 391
17.1.2 REVENUE ANALYSIS 391
17.1.3 COMPANY SHARE ANALYSIS 392
17.1.4 PRODUCT PORTFOLIO 392
17.1.5 RECENT DEVELOPMENT 392
17.2 HONEYWELL INTERNATIONAL INC. 393
17.2.1 COMPANY SNAPSHOT 393
17.2.2 REVENUE ANALYSIS 393
17.2.3 COMPANY SHARE ANALYSIS 394
17.2.4 PRODUCT PORTFOLIO 394
17.2.5 RECENT DEVELOPMENT 394
17.3 KIMBERLY-CLARK 395
17.3.1 COMPANY SNAPSHOT 395
17.3.2 REVENUE ANALYSIS 395
17.3.3 COMPANY SHARE ANALYSIS 396
17.3.4 PRODUCT PORTFOLIO 396
17.3.5 RECENT DEVELOPMENT 396
17.4 CARDINAL HEALTH 397
17.4.1 COMPANY SNAPSHOT 397
17.4.2 REVENUE ANALYSIS 397
17.4.3 COMPANY SHARE ANALYSIS 398
17.4.4 PRODUCT PORTFOLIO 398
17.4.5 RECENT DEVELOPMENT 398
17.5 OWENS & MINOR 399
17.5.1 COMPANY SNAPSHOT 399
17.5.2 REVENUE ANALYSIS 399
17.5.3 COMPANY SHARE ANALYSIS 400
17.5.4 PRODUCT PORTFOLIO 400
17.5.5 RECENT DEVELOPMENT 400
17.6 ALPHAPROTECH 401
17.6.1 COMPANY SNAPSHOT 401
17.6.2 REVENUE ANALYSIS 401
17.6.3 PRODUCT PORTFOLIO 402
17.6.4 RECENT DEVELOPMENT 402
17.7 MAKRITE 403
17.7.1 COMPANY SNAPSHOT 403
17.7.2 PRODUCT PORTFOLIO 403
17.7.3 RECENT DEVELOPMENT 403
17.8 MEDLINE INDUSTRIES, LP 404
17.8.1 COMPANY SNAPSHOT 404
17.8.2 PRODUCT PORTFOLIO 404
17.8.3 RECENT DEVELOPMENT 404
17.9 MOLDEX-METRIC 405
17.9.1 COMPANY SNAPSHOT 405
17.9.2 PRODUCT PORTFOLIO 405
17.9.3 RECENT DEVELOPMENT 406
17.10 PRESTIGE AMRITECH 407
17.10.1 COMPANY SNAPSHOT 407
17.10.2 PRODUCT PORTFOLIO 407
17.10.3 RECENT DEVELOPMENT 407
17.11 THE GERSON COMPANY 408
17.11.1 COMPANY SNAPSHOT 408
17.11.2 PRODUCT PORTFOLIO 408
17.11.3 RECENT DEVELOPMENT 408
18 QUESTIONNAIRE 409
19 RELATED REPORTS 413

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.